These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 27041580)

  • 1. A comprehensive profile of recurrent glioblastoma.
    Campos B; Olsen LR; Urup T; Poulsen HS
    Oncogene; 2016 Nov; 35(45):5819-5825. PubMed ID: 27041580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).
    Bryukhovetskiy I; Ponomarenko A; Lyakhova I; Zaitsev S; Zayats Y; Korneyko M; Eliseikina M; Mischenko P; Shevchenko V; Shanker Sharma H; Sharma A; Khotimchenko Y
    Int J Mol Med; 2018 Aug; 42(2):691-702. PubMed ID: 29749540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating recurrent glioblastoma: an update.
    Kamiya-Matsuoka C; Gilbert MR
    CNS Oncol; 2015; 4(2):91-104. PubMed ID: 25768333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming therapeutic resistance in glioblastoma: the way forward.
    Osuka S; Van Meir EG
    J Clin Invest; 2017 Feb; 127(2):415-426. PubMed ID: 28145904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response patterns of recurrent glioblastomas treated with tumor-treating fields.
    Vymazal J; Wong ET
    Semin Oncol; 2014 Oct; 41 Suppl 6():S14-24. PubMed ID: 25213870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent and ongoing clinical trials in glioblastoma.
    Lombardi G
    Clin Adv Hematol Oncol; 2018 Jul; 16(7):480-483. PubMed ID: 30067618
    [No Abstract]   [Full Text] [Related]  

  • 7. [Targeted therapy in glioblastoma: update and perspectives].
    Idbaih A; Duran-Peña A; Alentorn A
    Bull Acad Natl Med; 2015 Nov; 199(8-9):1323-1329. PubMed ID: 29874421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain malignancies: Glioblastoma and brain metastases.
    Lah TT; Novak M; Breznik B
    Semin Cancer Biol; 2020 Feb; 60():262-273. PubMed ID: 31654711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes.
    Hundsberger T; Hottinger AF; Roelcke U; Roth P; Migliorini D; Dietrich PY; Conen K; Pesce G; Hermann E; Pica A; Gross MW; Brügge D; Plasswilm L; Weller M; Putora PM
    J Neurooncol; 2016 Jan; 126(1):175-183. PubMed ID: 26459327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation.
    Katsila T; Matsoukas MT; Patrinos GP; Kardamakis D
    OMICS; 2017 Aug; 21(8):429-439. PubMed ID: 28816643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging therapeutic targets and agents for glioblastoma migrating cells.
    Di C; Mattox AK; Harward S; Adamson C
    Anticancer Agents Med Chem; 2010 Sep; 10(7):543-55. PubMed ID: 20950259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The stem cell niche in glioblastoma: from fundamental aspects to targeted therapies].
    Turpin A; Sharif A; Stoven L; Blond S; Maurage CA; Le Rhun É
    Bull Cancer; 2015 Jan; 102(1):24-33. PubMed ID: 25609493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroimaging: diagnosis and response assessment in glioblastoma.
    Clarke JL; Chang SM
    Cancer J; 2012; 18(1):26-31. PubMed ID: 22290254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma Therapy in the Age of Molecular Medicine.
    Geraldo LHM; Garcia C; da Fonseca ACC; Dubois LGF; de Sampaio E Spohr TCL; Matias D; de Camargo Magalhães ES; do Amaral RF; da Rosa BG; Grimaldi I; Leser FS; Janeiro JM; Macharia L; Wanjiru C; Pereira CM; Moura-Neto V; Freitas C; Lima FRS
    Trends Cancer; 2019 Jan; 5(1):46-65. PubMed ID: 30616755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult Glioblastoma.
    Alexander BM; Cloughesy TF
    J Clin Oncol; 2017 Jul; 35(21):2402-2409. PubMed ID: 28640706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence.
    Zygogianni A; Protopapa M; Kougioumtzopoulou A; Simopoulou F; Nikoloudi S; Kouloulias V
    Clin Transl Oncol; 2018 Aug; 20(8):989-1003. PubMed ID: 29335830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma Stem Cells-Useful Tools in the Battle against Cancer.
    Rodriguez SMB; Staicu GA; Sevastre AS; Baloi C; Ciubotaru V; Dricu A; Tataranu LG
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioblastoma stem cells.
    Tabatabai G; Weller M
    Cell Tissue Res; 2011 Mar; 343(3):459-65. PubMed ID: 21253762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.
    Kwon SM; Kang SH; Park CK; Jung S; Park ES; Lee JS; Kim SH; Woo HG
    PLoS One; 2015; 10(10):e0140528. PubMed ID: 26466313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma.
    Fedele M; Cerchia L; Pegoraro S; Sgarra R; Manfioletti G
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.